An analysis of the attrition of drug candidates from four major pharmaceutical companies
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The pharmaceutical industry remains under huge pressure to address the high attrition rates in drug development. Attempts to reduce the number of efficacy- and safety-related failures by analysing possible links to the physicochemical properties of small-molecule drug candidates have been inconclusive because of the limited size of data sets from individual companies. Here, we describe the compilation and analysis of combined data on the attrition of drug candidates from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline and Pfizer. The analysis reaffirms that control of physicochemical properties during compound optimization is beneficial in identifying compounds of candidate drug quality and indicates for the first time a link between the physicochemical properties of compounds and clinical failure due to safety issues. The results also suggest that further control of physicochemical properties is unlikely to have a significant effect on attrition rates and that additional work is required to address safety-related failures. Further cross-company collaborations will be crucial to future progress in this area.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Advancing drug safety assessment relies on bridging the translation gap between animal toxicology findings and clinical outcomes, a challenge with far-reaching consequences for R&D efficiency, regulatory success and patient safety (Waring et al., 2015; Amorim et al., 2024).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Waring et al., 2015
In the citing paper
“When using a polylactic acid–polyethylene glycol copolymer, the embedding rate reached 90%.”
From Synthesis and Biological Application of Polylactic Acid (2020) · cites this paper as [87]
In the citing paper
“Su et al. found that, when polylactic acid was used as the membrane material, the embedding rate of hemoglobin was very low, only 7.9%.”
From Synthesis and Biological Application of Polylactic Acid (2020) · cites this paper as [87]
In the citing paper
“The attrition rates in Phase II and Phase III development stages have been reported to be as high as 80% [75,344].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [75]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Self-citationLessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
Self-citation
Cited by
Items 801–900 of 1,001
NeuralDock: Rapid and Conformation-Agnostic Docking of Small Molecules
Sha, C. M., Wang, J., & Dokholyan, N. V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.867241 · Cited by 9
“Insuf fi cient binding af fi nities of leads and hits from Steps (1) and (2) often lead to drug attrition in Step (3) and subsequent clinical trials, with attrition rates as high as 95% (Hutchinson and Kirk, 2011; Waring et al., 2015).”
BackgroundSelf-citationExploring Benzo[h]chromene Derivatives as Agents against Protozoal and Mycobacterial Infections
Pertino, M., de la Torre, A. F., Schmeda‐Hirschmann, G., Vega, C., Rolón, M. S., Coronel, C., de Árias, A. R., Molina-Torres, C. A., Cabrera, L. V., & Viveros‐Valdez, E. (2024) · Pharmaceuticals · doi:10.3390/ph17101375 · Cited by 9
Caneus, J., Autar, K., Akanda, N., Grillo, M., Long, C. J., Jackson, M., Lindquist, S., Guo, X., Morgan, D., & Hickman, J. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-73869-9 · Cited by 9
Shi, Y., Cai, G., Zhang, C., Li, H., Nie, Y., Yu, S., Zhang, B., Wu, M., Luo, W., Liu, J., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114451 · Cited by 9
Sigma-1 Receptor Ligands for CNS Cancer Treatment
Prasansuklab, A., Safrany, S. T., Brimson, S., & Brimson, J. M. (2025) · CNS Drugs · doi:10.1007/s40263-025-01223-2 · Cited by 9
Li, Z., Wang, H., Liu, B., & Wang, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117418 · Cited by 9
Coumarin–benzimidazole hybrids: Design, synthesis and identification of potential anticancer agents
Arya, C. G., Thomas, N. M., Chandrakanth, M., Kallingal, A., Amrutha, P. G., Sivapriya, M. S., Gondru, R., & Banothu, J. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130444 · Cited by 9
Ito, S., Koyama, T., Matsumoto, S., Kojima, R., Okamoto, Y., Kuroda, M., Kawashima, H., Watanabe, R., Yonezawa, T., Sumiyoshi, T., et al. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00758 · Cited by 9
Urs, A. R., Selvi, V. G., Sreekumar, A., Sudarsan, A., Murthy, P. V., H, M. R. A., & Manokaran, S. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-08308-7 · Cited by 9
Artificial intelligence in antibiotic discovery: Applications, challenges, and future outlook
Xu, J. B., Li, C., Wang, X., Peleg, A. Y., LI, F., Song, J., & de la Fuente‐Núñez, C. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100445 · Cited by 9
Chen, C., Zhou, X., Lavezzi, S. M., Arshad, U., & Sharma, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-022-03849-y · Cited by 9
Peyear, T. A., & Andersen, O. S. (2023) · The Journal of General Physiology · doi:10.1085/jgp.202213247 · Cited by 9
Adaptation of Empirical Methods to Predict the LogD of Triazine Macrocycles
Patterson-Gardner, C. J., Pavelich, G. M., Cannon, A. T., Menke, A. J., & Simanek, E. E. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00290 · Cited by 9
Prasanth, D., Reddy, L. S. S. R. L. S. S., Dasari, T., Bhavanam, P. R., Ahmad, S. F., Nalluri, R., & Pasala, P. K. (2023) · Separations · doi:10.3390/separations10110552 · Cited by 9
ADME Optimization in Drug Discovery
McGinnity, D. F., & Grime, K. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781788018982-00298 · Cited by 9
Islam, M. R., Biswas, S., Amena, U., Rahman, M., Islam, S., Islam, M. A., Saleh, M. A., Hassan, H. M., Al‐Emam, A., & Zaki, M. E. A. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70116 · Cited by 9
de Castro, I. M., Antunes, C., Valentim, C. C., Spoladori, L. F. D. A., Suzukawa, H. T., Correia, G. F., Silva-Rodrigues, G., Borges, P. H. G., Bartolomeu-Gonçalves, G., Silva, M. L., et al. (2025) · Plants · doi:10.3390/plants14071059 · Cited by 9
Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists
Agarwal, S., Sasane, S., Kumar, J., Darji, B., Bhayani, H., Soman, S. S., Kulkarni, N. D., & Jain, M. R. (2019) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2019.100002 · Cited by 9
Luo, D., & Luesch, H. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00473 · Cited by 9
Prediction of Active Drug Molecule using Back-Propagation Neural Network
Mandal, L., & Jana, N. D. (2019) · International Conference on System Modeling & Advancement in Research Trends (SMART) · doi:10.1109/smart46866.2019.9117378 · Cited by 9
Curreli, F., Ahmed, S., Victor, S. M. B., Drelich, A. K., Panda, S. S., Altieri, A., Kurkin, A. V., Tseng, C.-T. K., Hillyer, C. D., & Debnath, A. K. (2021) · Viruses · doi:10.3390/v14010069 · Cited by 9
Recent advances and future prospects of functional organ-on-a-chip systems
Moghaddam, A. S., Moghaddam, Z. S., Davachi, S. M., Sarikhani, E., Mahand, S. N., Khonakdar, H. A., Bagher, Z., & Ashammakhi, N. A. (2022) · Materials Chemistry Frontiers · doi:10.1039/d2qm00072e · Cited by 9
AI and Big Data for Drug Discovery
Kavidopoulou, A., Syrigos, K. N., Makrogkikas, S., Dlamini, Z., Hull, R., Marima, R. M., Skepu, A., Koumoulos, E. P., Bakas, G., Vamvakaris, I. N., et al. (2022) · Integrated science · doi:10.1007/978-3-031-11199-0_7 · Cited by 9
Many are called, few are chosen: the role of science in drug development decisions
Colen, L., Belderbos, R., Kelchtermans, S., & Leten, B. (2023) · The Journal of Technology Transfer · doi:10.1007/s10961-022-09982-6 · Cited by 9
Moreno, M. J., & Salvador, A. (2023) · Molecules · doi:10.3390/molecules28073136 · Cited by 9
Assessing seizure liability in vitro with voltage-sensitive dye imaging in mouse hippocampal slices
Utsumi, Y., Taketoshi, M., Miwa, M., Tominaga, Y., & Tominaga, T. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1217368 · Cited by 9
Boutin, R., Lee, H., Guan, T. L., Nguyen, T. T., Huang, X. F., Waller, D. D., Lu, J., Chio, I. I. C., Michel, R. P., Sébag, M., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01271 · Cited by 9
Liu, J., Vernikovskaya, D. I., Bora, G., Carlo, A. A., Burchett, W., Jordan, S., Tang, L. W. T., Yang, J. C., Che, Y., Chang, G., et al. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00908-8 · Cited by 9
Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist
Agarwal, S., Sasane, S., Deshmukh, P. H., Bhadresh, R., Bandyopadhyay, D., Giri, P., Giri, S. R., Jain, M. R., & Desai, R. C. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00331 · Cited by 9
Lessons and Successes in the Use of Molecular Fields
Tosco, P., & Mackey, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12353-4 · Cited by 9
Industrial medicinal chemistry insights: neuroscience hit generation at Janssen
Tresadern, G., Rombouts, F. J. R., Oehlrich, D., Macdonald, G. J., & Trabanco, A. A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.013 · Cited by 9
Lesko, L. J. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.916 · Cited by 9
Exploring Polypharmacology in Drug Design
Méndez, P. S., & Eriksson, L. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8630-9_13 · Cited by 9
Aleo, M. D., Ukairo, O. T., Moore, A., Irrechukwu, O., Potter, D. M., & Schneider, R. P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3805 · Cited by 9
Should the United States government regulate prescription prices? A critical review
Patterson, J. A., & Carroll, N. V. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.06.010 · Cited by 9
Liu, Q., Xiao, H., Batt, D. G., Xiao, Z., Zhu, Y., Yang, M. G., Li, N., Yip, S. H., Li, P., Sun, D., et al. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00112 · Cited by 9
Self-citationD’Souza, S., Prema, K. V., & Balaji, S. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2134340 · Cited by 9
Shah, A. A., Chenard, L. K., Tucker, J. W., & Helal, C. J. (2017) · ACS Combinatorial Science · doi:10.1021/acscombsci.7b00116 · Cited by 9
Technical aspects of megaureter repair.
Hendren, W. H. (1977) · PubMed · Cited by 9
Towards Creating the Perfect In Vitro Cell Model
Jonsson, M. K. B., van Veen, T. A. B., Synnergren, J., & Becker, B. (2016) · Stem Cells International · doi:10.1155/2016/3459730 · Cited by 9
Jobin, C. (2022) · theses.fr (ABES) · doi:10.70675/a21ccaf7z8d27z409azbd71ze1388c14156d · Cited by 9
Wright, P. S. R., Briggs, K. A., Thomas, R., Smith, G. F., Maglennon, G., Mikulskis, P., Chapman, M., Greene, N., Phillips, B. U., & Bender, A. (2023) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2022.105308 · Cited by 8
The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law
Tropsha, A., Martin, H., & Cherkasov, A. R. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104341 · Cited by 8
Chandrakanth, M., Mishra, S., Gayathri, K., Katreddy, R. R., Ranganathan, S., G, A. C., Gondru, R., Rajasekaran, S., & Banothu, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118435 · Cited by 8
Mitsiadis, T. A., & Pagella, P. (2025) · Journal of Endodontics · doi:10.1016/j.joen.2025.12.008 · Cited by 8
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision
Furukawa, S., Uchida, H., & Kishimoto, T. (2026) · Pharmacopsychiatry · doi:10.1055/a-2810-8972 · Cited by 8
Kim, Y. H., Son, Y. H., Choi, Y., Kim, M. S., Park, S., & Lee, K. Y. (2026) · Microsystems & Nanoengineering · doi:10.1038/s41378-026-01249-6 · Cited by 8
Analysis of metabolites in human gut: illuminating the design of gut-targeted drugs
Gil-Pichardo, A., Sánchez-Ruiz, A., & Colmenarejo, G. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00768-y · Cited by 8
Crouzet, A., Lopez, N., Riss‐Yaw, B., Lepelletier, Y., & Demange, L. (2024) · Molecules · doi:10.3390/molecules29122716 · Cited by 8
CNS Drug Discovery in Academia: Where Basic Research Meets Innovation
Gertsch, J., & Chicca, A. (2024) · ChemBioChem · doi:10.1002/cbic.202400397 · Cited by 8
A virtual scalable model of the Hepatic Lobule for acetaminophen hepatotoxicity prediction
Pinto, S. C. D., Cherkaoui, J., Ghosh, D., Cazaubon, V., Benzeroual, K. E., Levine, S. M., Cherkaoui, M., Sood, G., Anandasabapathy, S., Dhingra, S., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01349-5 · Cited by 8
Analyzing Oxygen Atom Distribution in FDA‐Approved Drugs to Enhance Drug Discovery Strategies
Masand, V. H., Patil, M. K., Al‐Hussain, S. A., Samad, A., Rastija, V., Jawarkar, R. D., Masand, G. S., Gawali, R. G., & Zaki, M. E. A. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70060 · Cited by 8
Near‐Infrared Chemiluminescent Theranostics
Lin, Y., Huang, J., & Pu, K. (2025) · Angewandte Chemie · doi:10.1002/ange.202501681 · Cited by 8
Poreddy, S., Gundluru, M., Pothuraju, S., Bellala, P., Arya, J. S., & Cirandur, S. R. (2025) · Research on Chemical Intermediates · doi:10.1007/s11164-025-05590-9 · Cited by 8
Meirson, T., Samson, A. O., & Gil-Henn, H. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s136150 · Cited by 8
Hanson, E. D., Mayekar, S., & Dravid, V. P. (2017) · MRS Energy & Sustainability · doi:10.1557/mre.2017.12 · Cited by 8
Gomez‐Galeno, J., Okolotowicz, K. J., Johnson, M., McKeithan, W. L., Mercola, M. A., & Cashman, J. R. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.828 · Cited by 8
Organs-on-chip models for cardiovascular drug development
Zimmermann, W. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab229 · Cited by 8
Aplicaciones de la inteligencia artificial en la farmacología básica y clínica
Matsingos, C., Urdaneta, A. M., Hernández, J. C., & Silva, R. A. P. (2022) · Medicina · doi:10.56050/01205498.1652 · Cited by 8
Development of Pharmacophore Models for the Important Off-Target 5-HT2B Receptor
Schieferdecker, S., & Vock, E. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01679 · Cited by 8
Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators
Barcherini, V., Loureiro, J. B., Sena, A., Madeira, C. A. C., Leandro, P., Saraiva, L., Antunes, A. M. M., & Santos, M. M. M. (2023) · Pharmaceuticals · doi:10.3390/ph16020146 · Cited by 8
Vashi, Y., Nehru, G., & Kumar, S. (2022) · Virology · doi:10.1016/j.virol.2023.06.010 · Cited by 8
Comprehensive Network Map of ADME‐Tox Databases
Canault, B., Bourg, S., Vayer, P., & Bonnet, P. (2017) · Molecular Informatics · doi:10.1002/minf.201700029 · Cited by 8
Kiani, Y. S., & Jabeen, I. (2019) · Computation · doi:10.3390/computation7020026 · Cited by 8
A Case Report: Building communities with training and resources for Open Science trainers
Brinken, H., Kuchma, I., Kalaitzi, V., Davidson, J., Pontika, N., Cancellieri, M., Correia, A., Carvalho, J., Melero, R., Kastelic, D., et al. (2019) · LIBER Quarterly The Journal of the Association of European Research Libraries · doi:10.18352/lq.10303 · Cited by 8
Undersampling: case studies of flaviviral inhibitory activities
Barigye, S. J., de la Vega, J. M. G., & Castillo‐Garit, J. A. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00255-3 · Cited by 8
Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century
Sanghai, N., Shafiq, K., & Tranmer, G. K. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520999200824103803 · Cited by 8
Okura, R., Uchiyama, H., Kadota, K., & Tozuka, Y. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00896 · Cited by 8
ZHENG, K. C., Li, D., Liu, J., Li, X., Xie, C., Feng, L., Qin, J., Qian, S., & Pang, Q. (2021) · Acta Crystallographica Section B Structural Science Crystal Engineering and Materials · doi:10.1107/s2052520621003085 · Cited by 8
de Lamotte, J. D., Perrier, A. L., Martinat, C., & Nicoleau, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147524 · Cited by 8
Zhuo, X., Howell, B. A., Shen, H., Woodhead, J. L., Mosure, K., Zhang, Y., Scialis, R. J., Iyer, R. A., Sun, Y., Boy, K. M., et al. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad057 · Cited by 8
Noji, S., Seki, N., Maeba, T., Sakai, T., Watanabe, E., Maeda, K., Fukushima, K., Noguchi, T., Kazuya, O., Toyonaga, Y., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00232 · Cited by 8
Multi‐objective Optimization of Benzamide Derivatives as Rho Kinase Inhibitors
Gajo, G. C., Silva, D. R., Barigye, S. J., & da Cunha, E. F. F. (2017) · Molecular Informatics · doi:10.1002/minf.201700080 · Cited by 8
Cerebrospinal Fluid Characterization in Cynomolgus Monkeys, Beagle Dogs, and Göttingen Minipigs
Ballesteros, C., Pouliot, M., Froment, R., Maghezzi, M. S., St‐Jean, C., Li, C., Paquette, D., & Authier, S. (2020) · International Journal of Toxicology · doi:10.1177/1091581820905092 · Cited by 8
A Benchmarking Dataset with 2440 Organic Molecules for Volume Distribution at Steady StatePreprint
Liu, W., Luo, C., Wang, H., & Meng, F. (2022) · arXiv (Cornell University) · doi:10.48550/arxiv.2211.05661 · Cited by 8
Kenna, J. G. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1290082 · Cited by 7
Pore, S., & Roy, K. (2025) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2025.100093 · Cited by 7
Cyboran-Mikołajczyk, S., Matczak, K., Kaźmierczak, T., Trochanowska-Pauk, N., Walski, T., Bohara, R. A., Bukowski, K., Krawczyk-Łebek, A., & Kostrzewa-Susłow, E. (2025) · Cells · doi:10.3390/cells14161299 · Cited by 7
Batlle, E., Pequerul, R., Farrés, J., Eriksson, L. A., Pors, K., & Jha, V. (2025) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-025-00622-3 · Cited by 7
Balakumar, P., Mulukuri, N. V. L. S., & Jagadeesh, G. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108945 · Cited by 7
Caged Polyprenylated Xanthones in Garcinia hanburyi and the Biological Activities of Them
He, R.-X., Jia, B., Peng, D., & Chen, W. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s426685 · Cited by 7
Berridge, B. R., Pierson, J. B., Pettit, S. D., & Stockbridge, N. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1352783 · Cited by 7
Liu, M., Feng, B., Chu, F., Fan, D., Zheng, F., Chen, F., & Zeng, W. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.110043 · Cited by 7
In vitro human ion channel assays predictive of drug-induced seizure
Cohen, J. D., You, D., Sharma, A. K., Takai, T., Hara, H., Sales, V. T., Yukawa, T., & Cai, B. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae148 · Cited by 7
Molecular Docking & In Silico ADME Analysis of 5-O-Methyl-11-O-Acetylalkannin
Sardar, H., Shareef, U., & Khan, H. Z. (2024) · Phytopharmacological communications. · doi:10.55627/ppc.004.001.0523 · Cited by 7
PPDPF preserves integrity of proximal tubule by modulating NMNAT activity in chronic kidney diseases
Fang, X., Zhong, Y., Zheng, R., Wu, Q., Liu, Y., Zhang, D., Wang, Y., Ding, W., Wang, K., Zhong, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr8648 · Cited by 7
Precision, Prediction and Progress: A New Era in Pharmacology
Singh, J. P., Gaur, V., & Dubey, P. (2025) · doi:10.38124/ijisrt/25apr1322 · Cited by 7
Quantum Machine Learning for Drug Discovery: Taxonomy, Research Challenges, and the Road Ahead
Duong, Y. H. P., Rizvi, S. M. A., McNiven, B. D. E., Nguyen, T. T., Shin, H., Dobre, O. A., & Duong, T. Q. (2025) · ACM Computing Surveys · doi:10.1145/3785660 · Cited by 7
Pajzderska, A., Mielcarek, J., & Wąsicki, J. W. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02234-8 · Cited by 7
Gomes, A. S., Correia, A., Rahikkala, A., Mäkilä, E. M., Pinto, M. M. M., Sousa, E., Salonen, J., Saraiva, L., & Santos, H. A. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121959 · Cited by 7
Vangala, S., Saxena, U., & Chandran, C. S. (2022) · Springer eBooks · doi:10.1007/978-981-19-1379-2_29 · Cited by 7
Teaching Computer-Aided Drug Design Using TeachOpenCADD
Sydow, D., Rodríguez-Guerra, J., & Volkamer, A. (2021) · ACS symposium series · doi:10.1021/bk-2021-1387.ch010 · Cited by 7
Targeting the tamoxifen receptor within sodium channels to block osteoarthritic pain
McCollum, M. M., Larmore, M. J., Ishihara, S., Ng, L. C. T., Kimura, L. F., Guadarrama, E., Ta, M. C., Vien, T. N., Frost, G. B., Scheidt, K. A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111248 · Cited by 7
Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing
Sudaki, H., Fujimoto, K., Wada, K., & Sugano, K. (2023) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2023.100519 · Cited by 7
Kelsall, K. N., Schubiner, R. O., Schenck, L., Frank, D. S., & Matzger, A. J. (2024) · ACS Applied Polymer Materials · doi:10.1021/acsapm.3c02882 · Cited by 7
Fallon, I., Hernando, H., Almacellas‐Rabaiget, O., Martí-Fuster, B., Spadoni, C., Bigner, D. D., & Méndez, E. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.100147 · Cited by 7
Stone, C. D., Sabe, S. A., Harris, D. D., Broadwin, M., Kant, R. J., Kanuparthy, M., Abid, M. R., & Sellke, F. W. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006437 · Cited by 7
Dehnert, B. W., Yin, Y., & Kwon, O. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c04084 · Cited by 7
Emerging RNA editing biomarkers will foster drug development
van der Laan, S., Salvetat, N., Weissmann, D., & Molina, F. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.017 · Cited by 7
The use of human tissue in safety assessment
Jackson, S. J., Prior, H. M., & Holmes, A. M. (2018) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2018.05.003 · Cited by 7
Metadata
- Authors
- Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., Wallace, O., & Weir, A.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Thomson Reuters (United Kingdom) (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Pfizer (United Kingdom) (GB)
- Eli Lilly (United States) (US)
- Corresponding author
- Waring, Michael J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-06-19
- Volume
- 14
- Issue
- 7
- Pages
- 475-486
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1663154925
- Cited by
- 1,450
- References
- 27
- Citations by year
- 2026: 164 · 2025: 116 · 2024: 148 · 2023: 143 · 2022: 140 · 2021: 131 · 2020: 129 · 2019: 129 · 2018: 129 · 2017: 113 · 2016: 94 · 2015: 11
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Pfizer
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- drug attrition, small molecule drug candidates, physicochemical properties, clinical failure, drug safety, compound optimization, oral medication, pharmaceutical industry
- MeSH terms
- Animals, Drug Industry, Drug Evaluation, Preclinical, Humans, Statistics as Topic, Drugs, Investigational, Drug Delivery Systems, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.